Anti-interferon-γ autoantibody-mediated immunodeficiency with disseminated Mycobacterium massiliense and secondary Sweet syndrome: A case report
Abstract
RATIONALE: The co-occurrence of adult-onset immunodeficiency syndrome mediated by anti-interferon-γ autoantibodies (AIGA-AOID), disseminated non-tuberculous mycobacterial (NTM) infection, and Sweet syndrome is a recognized but underreported triad, particularly in East Asian populations. Detailed case reports emphasizing diagnostic approach and integrated management remain valuable for improving clinical recognition.
PATIENT CONCERNS: A 70-year-old Asian female presented with a 1-year history of a progressive neck mass, a 6-month history of recurrent fever, and a painful cutaneous eruption on the face, trunk, and limbs.
DIAGNOSES: Evaluations revealed disseminated Mycobacterium massiliense infection involving lymph nodes, lung, and skin. Skin biopsy was consistent with Sweet syndrome. High-titer anti-interferon-γ autoantibodies (1:2500) were detected, confirming AIGA-AOID in the absence of HIV or other immunosuppression.
INTERVENTIONS: Combined therapy was initiated: rituximab (two weekly doses) with corticosteroids, and a 12-month oral antimycobacterial regimen (clarithromycin, moxifloxacin, linezolid).
OUTCOMES: The patient showed marked clinical improvement within 2 weeks, with resolution of fever and skin healing. Follow-up imaging at 3 months demonstrated significant regression of lymphadenopathy and lung consolidation.
LESSONS: Sweet syndrome can be a presenting sign of disseminated NTM disease. In immunocompetent-appearing adults, especially in endemic regions, this…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.